APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Pharmaceutical Market Outlook and Growth Opportunities 2026

27 December 2025198 pages

Choose your research edition.

Industry ResearchAnimal Pharmaceutical Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Pharmaceutical Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Animal Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Pharmaceutical Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Pharmaceutical Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Animal Pharmaceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Pharmaceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Pharmaceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Pharmaceutical market include Merck, Zoetis, Virbac, Vétoquinol, Ringpu Biology, PARNELL, MSD Animal Health Australia, Merial and Jurox, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Pharmaceutical market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Pharmaceutical and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Pharmaceutical sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Pharmaceutical market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Pharmaceutical Segment by Company

Merck

Zoetis

Virbac

Vétoquinol

Ringpu Biology

PARNELL

MSD Animal Health Australia

Merial

Jurox

Elanco

Ceva Sante Animale

CAHIC

Boehringer Ingelheim Vetmedica

Bayer Animal Health

Animal Pharmaceutical Segment by Type

Vaccine

Veterinary Drugs

Other

Animal Pharmaceutical Segment by Application

Companion Animal

Poultry

Other

Animal Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal Pharmaceutical status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal Pharmaceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Pharmaceutical significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Pharmaceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Pharmaceutical market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Pharmaceutical industry.

Chapter 3: Detailed analysis of Animal Pharmaceutical manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal Pharmaceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal Pharmaceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Pharmaceutical Industry Trends Table 2. Animal Pharmaceutical Industry Drivers Table 3. Animal Pharmaceutical Industry Opportunities and Challenges Table 4. Animal Pharmaceutical Industry Restraints Table 5. Global Animal Pharmaceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Pharmaceutical Revenue Share by Company (2021-2026) Table 7. Global Animal Pharmaceutical Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Animal Pharmaceutical Sales Volume Share by Company (2021-2026) Table 9. Global Animal Pharmaceutical Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Animal Pharmaceutical Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal Pharmaceutical Key Company Manufacturing Base & Headquarters Table 12. Global Animal Pharmaceutical Company, Product Type & Application Table 13. Global Animal Pharmaceutical Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vaccine Table 18. Significant Companies of Veterinary Drugs Table 19. Significant Companies of Other Table 20. Global Animal Pharmaceutical Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Animal Pharmaceutical Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Animal Pharmaceutical Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Animal Pharmaceutical Sales Volume Share by Type (2021-2026) Table 24. Global Animal Pharmaceutical Sales Volume Share by Type (2027-2032) Table 25. Global Animal Pharmaceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Animal Pharmaceutical Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Animal Pharmaceutical Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Animal Pharmaceutical Sales Value Share by Type (2021-2026) Table 29. Global Animal Pharmaceutical Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Companion Animal Table 31. Significant Companies of Poultry Table 32. Significant Companies of Other Table 33. Global Animal Pharmaceutical Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Animal Pharmaceutical Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Animal Pharmaceutical Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Animal Pharmaceutical Sales Volume Share by Application (2021-2026) Table 37. Global Animal Pharmaceutical Sales Volume Share by Application (2027-2032) Table 38. Global Animal Pharmaceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Animal Pharmaceutical Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Animal Pharmaceutical Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Animal Pharmaceutical Sales Value Share by Application (2021-2026) Table 42. Global Animal Pharmaceutical Sales Value Share by Application (2027-2032) Table 43. Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Animal Pharmaceutical Sales by Region (2021-2026) & (Tons) Table 45. Global Animal Pharmaceutical Sales Market Share by Region (2021-2026) Table 46. Global Animal Pharmaceutical Sales by Region (2027-2032) & (Tons) Table 47. Global Animal Pharmaceutical Sales Market Share by Region (2027-2032) Table 48. Global Animal Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Animal Pharmaceutical Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Animal Pharmaceutical Sales Value Share by Region (2021-2026) Table 51. Global Animal Pharmaceutical Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Animal Pharmaceutical Sales Value Share by Region (2027-2032) Table 53. Global Animal Pharmaceutical Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Animal Pharmaceutical Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Animal Pharmaceutical Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Animal Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Animal Pharmaceutical Sales by Country (2021-2026) & (Tons) Table 58. Global Animal Pharmaceutical Sales Market Share by Country (2021-2026) Table 59. Global Animal Pharmaceutical Sales by Country (2027-2032) & (Tons) Table 60. Global Animal Pharmaceutical Sales Market Share by Country (2027-2032) Table 61. Global Animal Pharmaceutical Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Animal Pharmaceutical Sales Value Market Share by Country (2021-2026) Table 63. Global Animal Pharmaceutical Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Animal Pharmaceutical Sales Value Market Share by Country (2027-2032) Table 65. Merck Company Information Table 66. Merck Business Overview Table 67. Merck Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Merck Animal Pharmaceutical Product Portfolio Table 69. Merck Recent Development Table 70. Zoetis Company Information Table 71. Zoetis Business Overview Table 72. Zoetis Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Zoetis Animal Pharmaceutical Product Portfolio Table 74. Zoetis Recent Development Table 75. Virbac Company Information Table 76. Virbac Business Overview Table 77. Virbac Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Virbac Animal Pharmaceutical Product Portfolio Table 79. Virbac Recent Development Table 80. Vétoquinol Company Information Table 81. Vétoquinol Business Overview Table 82. Vétoquinol Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Vétoquinol Animal Pharmaceutical Product Portfolio Table 84. Vétoquinol Recent Development Table 85. Ringpu Biology Company Information Table 86. Ringpu Biology Business Overview Table 87. Ringpu Biology Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Ringpu Biology Animal Pharmaceutical Product Portfolio Table 89. Ringpu Biology Recent Development Table 90. PARNELL Company Information Table 91. PARNELL Business Overview Table 92. PARNELL Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. PARNELL Animal Pharmaceutical Product Portfolio Table 94. PARNELL Recent Development Table 95. MSD Animal Health Australia Company Information Table 96. MSD Animal Health Australia Business Overview Table 97. MSD Animal Health Australia Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. MSD Animal Health Australia Animal Pharmaceutical Product Portfolio Table 99. MSD Animal Health Australia Recent Development Table 100. Merial Company Information Table 101. Merial Business Overview Table 102. Merial Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Merial Animal Pharmaceutical Product Portfolio Table 104. Merial Recent Development Table 105. Jurox Company Information Table 106. Jurox Business Overview Table 107. Jurox Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Jurox Animal Pharmaceutical Product Portfolio Table 109. Jurox Recent Development Table 110. Elanco Company Information Table 111. Elanco Business Overview Table 112. Elanco Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Elanco Animal Pharmaceutical Product Portfolio Table 114. Elanco Recent Development Table 115. Ceva Sante Animale Company Information Table 116. Ceva Sante Animale Business Overview Table 117. Ceva Sante Animale Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Ceva Sante Animale Animal Pharmaceutical Product Portfolio Table 119. Ceva Sante Animale Recent Development Table 120. CAHIC Company Information Table 121. CAHIC Business Overview Table 122. CAHIC Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. CAHIC Animal Pharmaceutical Product Portfolio Table 124. CAHIC Recent Development Table 125. Boehringer Ingelheim Vetmedica Company Information Table 126. Boehringer Ingelheim Vetmedica Business Overview Table 127. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio Table 129. Boehringer Ingelheim Vetmedica Recent Development Table 130. Bayer Animal Health Company Information Table 131. Bayer Animal Health Business Overview Table 132. Bayer Animal Health Animal Pharmaceutical Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 133. Bayer Animal Health Animal Pharmaceutical Product Portfolio Table 134. Bayer Animal Health Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Animal Pharmaceutical Distributors List Table 138. Animal Pharmaceutical Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Animal Pharmaceutical Product Image Figure 2. Global Animal Pharmaceutical Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal Pharmaceutical Sales (2021-2032) & (Tons) Figure 5. Global Animal Pharmaceutical Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Animal Pharmaceutical Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vaccine Image Figure 10. Veterinary Drugs Image Figure 11. Other Image Figure 12. Global Animal Pharmaceutical Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Animal Pharmaceutical Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Animal Pharmaceutical Sales Volume Share by Type (2021-2032) Figure 15. Global Animal Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Animal Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Animal Pharmaceutical Sales Value Share by Type (2021-2032) Figure 18. Companion Animal Image Figure 19. Poultry Image Figure 20. Other Image Figure 21. Global Animal Pharmaceutical Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Animal Pharmaceutical Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Animal Pharmaceutical Sales Volume Share by Application (2021-2032) Figure 24. Global Animal Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Animal Pharmaceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Animal Pharmaceutical Sales Value Share by Application (2021-2032) Figure 27. Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Animal Pharmaceutical Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Animal Pharmaceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Animal Pharmaceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 32. North America Animal Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Animal Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Animal Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 38. South America Animal Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Animal Pharmaceutical Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Animal Pharmaceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Animal Pharmaceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Animal Pharmaceutical Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Animal Pharmaceutical Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Veterinary Drugs
  • Other
Applications
  • Companion Animal
  • Poultry
  • Other
Companies covered
  • Merck
  • Zoetis
  • Virbac
  • Vétoquinol
  • Ringpu Biology
  • PARNELL
  • MSD Animal Health Australia
  • Merial
  • Jurox
  • Elanco
  • Ceva Sante Animale
  • CAHIC
  • Boehringer Ingelheim Vetmedica
  • Bayer Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Pharmaceutical Sales Value (2021-2032)
  4. 1.2.2 Global Animal Pharmaceutical Sales Volume (2021-2032)
  5. 1.2.3 Global Animal Pharmaceutical Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal Pharmaceutical Market Dynamics
  1. 2.1 Animal Pharmaceutical Industry Trends
  2. 2.2 Animal Pharmaceutical Industry Drivers
  3. 2.3 Animal Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 Animal Pharmaceutical Industry Restraints
3 Animal Pharmaceutical Market by Company
  1. 3.1 Global Animal Pharmaceutical Company Revenue Ranking in 2025
  2. 3.2 Global Animal Pharmaceutical Revenue by Company (2021-2026)
  3. 3.3 Global Animal Pharmaceutical Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal Pharmaceutical Average Price by Company (2021-2026)
  5. 3.5 Global Animal Pharmaceutical Company Ranking (2024-2026)
  6. 3.6 Global Animal Pharmaceutical Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal Pharmaceutical Company Product Type and Application
  8. 3.8 Global Animal Pharmaceutical Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal Pharmaceutical Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal Pharmaceutical Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal Pharmaceutical Market by Type
  1. 4.1 Animal Pharmaceutical Type Introduction
  2. 4.1.1 Vaccine
  3. 4.1.2 Veterinary Drugs
  4. 4.1.3 Other
  5. 4.2 Global Animal Pharmaceutical Sales Volume by Type
  6. 4.2.1 Global Animal Pharmaceutical Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Animal Pharmaceutical Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Animal Pharmaceutical Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Animal Pharmaceutical Sales Value by Type
  10. 4.3.1 Global Animal Pharmaceutical Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Animal Pharmaceutical Sales Value by Type (2021-2032)
  12. 4.3.3 Global Animal Pharmaceutical Sales Value Share by Type (2021-2032)
5 Animal Pharmaceutical Market by Application
  1. 5.1 Animal Pharmaceutical Application Introduction
  2. 5.1.1 Companion Animal
  3. 5.1.2 Poultry
  4. 5.1.3 Other
  5. 5.2 Global Animal Pharmaceutical Sales Volume by Application
  6. 5.2.1 Global Animal Pharmaceutical Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Animal Pharmaceutical Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Animal Pharmaceutical Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Animal Pharmaceutical Sales Value by Application
  10. 5.3.1 Global Animal Pharmaceutical Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Animal Pharmaceutical Sales Value by Application (2021-2032)
  12. 5.3.3 Global Animal Pharmaceutical Sales Value Share by Application (2021-2032)
6 Animal Pharmaceutical Regional Sales and Value Analysis
  1. 6.1 Global Animal Pharmaceutical Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Pharmaceutical Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Pharmaceutical Sales by Region: 2021-2026
  4. 6.2.2 Global Animal Pharmaceutical Sales by Region (2027-2032)
  5. 6.3 Global Animal Pharmaceutical Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal Pharmaceutical Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal Pharmaceutical Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal Pharmaceutical Sales Value by Region (2027-2032)
  9. 6.5 Global Animal Pharmaceutical Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal Pharmaceutical Sales Value (2021-2032)
  12. 6.6.2 North America Animal Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal Pharmaceutical Sales Value (2021-2032)
  15. 6.7.2 Europe Animal Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal Pharmaceutical Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal Pharmaceutical Sales Value (2021-2032)
  21. 6.9.2 South America Animal Pharmaceutical Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal Pharmaceutical Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal Pharmaceutical Sales Value Share by Country, 2025 VS 2032
7 Animal Pharmaceutical Country-level Sales and Value Analysis
  1. 7.1 Global Animal Pharmaceutical Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Pharmaceutical Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal Pharmaceutical Sales by Country (2021-2032)
  4. 7.3.1 Global Animal Pharmaceutical Sales by Country (2021-2026)
  5. 7.3.2 Global Animal Pharmaceutical Sales by Country (2027-2032)
  6. 7.4 Global Animal Pharmaceutical Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal Pharmaceutical Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal Pharmaceutical Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal Pharmaceutical Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal Pharmaceutical Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal Pharmaceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Animal Pharmaceutical Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Animal Pharmaceutical Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Virbac
  14. 8.3.1 Virbac Company Information
  15. 8.3.2 Virbac Business Overview
  16. 8.3.3 Virbac Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Virbac Animal Pharmaceutical Product Portfolio
  18. 8.3.5 Virbac Recent Developments
  19. 8.4 Vétoquinol
  20. 8.4.1 Vétoquinol Company Information
  21. 8.4.2 Vétoquinol Business Overview
  22. 8.4.3 Vétoquinol Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vétoquinol Animal Pharmaceutical Product Portfolio
  24. 8.4.5 Vétoquinol Recent Developments
  25. 8.5 Ringpu Biology
  26. 8.5.1 Ringpu Biology Company Information
  27. 8.5.2 Ringpu Biology Business Overview
  28. 8.5.3 Ringpu Biology Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ringpu Biology Animal Pharmaceutical Product Portfolio
  30. 8.5.5 Ringpu Biology Recent Developments
  31. 8.6 PARNELL
  32. 8.6.1 PARNELL Company Information
  33. 8.6.2 PARNELL Business Overview
  34. 8.6.3 PARNELL Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 PARNELL Animal Pharmaceutical Product Portfolio
  36. 8.6.5 PARNELL Recent Developments
  37. 8.7 MSD Animal Health Australia
  38. 8.7.1 MSD Animal Health Australia Company Information
  39. 8.7.2 MSD Animal Health Australia Business Overview
  40. 8.7.3 MSD Animal Health Australia Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MSD Animal Health Australia Animal Pharmaceutical Product Portfolio
  42. 8.7.5 MSD Animal Health Australia Recent Developments
  43. 8.8 Merial
  44. 8.8.1 Merial Company Information
  45. 8.8.2 Merial Business Overview
  46. 8.8.3 Merial Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Merial Animal Pharmaceutical Product Portfolio
  48. 8.8.5 Merial Recent Developments
  49. 8.9 Jurox
  50. 8.9.1 Jurox Company Information
  51. 8.9.2 Jurox Business Overview
  52. 8.9.3 Jurox Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jurox Animal Pharmaceutical Product Portfolio
  54. 8.9.5 Jurox Recent Developments
  55. 8.10 Elanco
  56. 8.10.1 Elanco Company Information
  57. 8.10.2 Elanco Business Overview
  58. 8.10.3 Elanco Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Elanco Animal Pharmaceutical Product Portfolio
  60. 8.10.5 Elanco Recent Developments
  61. 8.11 Ceva Sante Animale
  62. 8.11.1 Ceva Sante Animale Company Information
  63. 8.11.2 Ceva Sante Animale Business Overview
  64. 8.11.3 Ceva Sante Animale Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ceva Sante Animale Animal Pharmaceutical Product Portfolio
  66. 8.11.5 Ceva Sante Animale Recent Developments
  67. 8.12 CAHIC
  68. 8.12.1 CAHIC Company Information
  69. 8.12.2 CAHIC Business Overview
  70. 8.12.3 CAHIC Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 CAHIC Animal Pharmaceutical Product Portfolio
  72. 8.12.5 CAHIC Recent Developments
  73. 8.13 Boehringer Ingelheim Vetmedica
  74. 8.13.1 Boehringer Ingelheim Vetmedica Company Information
  75. 8.13.2 Boehringer Ingelheim Vetmedica Business Overview
  76. 8.13.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Vetmedica Recent Developments
  79. 8.14 Bayer Animal Health
  80. 8.14.1 Bayer Animal Health Company Information
  81. 8.14.2 Bayer Animal Health Business Overview
  82. 8.14.3 Bayer Animal Health Animal Pharmaceutical Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bayer Animal Health Animal Pharmaceutical Product Portfolio
  84. 8.14.5 Bayer Animal Health Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Pharmaceutical Value Chain Analysis
  2. 9.1.1 Animal Pharmaceutical Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Pharmaceutical Sales Mode & Process
  6. 9.2 Animal Pharmaceutical Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Pharmaceutical Distributors
  9. 9.2.3 Animal Pharmaceutical Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst